Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02924363 · ClinicalTrials.gov registry record
Effect of MitraClip on Acute and Chronic Reverse Cardiac Remodeling Assessed by CMR: The MITRA-REVERSE Study
A clinical trial, sponsored by Dipan Shah.
- Completed
- Registry status
- 54
- Enrollment target
NCT02924363: Completed study, sponsored by Dipan Shah.
NCT02924363 is a clinical trial that has completed, run by Dipan Shah. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02924363 has completed, sponsored by Dipan Shah.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to use cardiac magnetic resonance (CMR) and echocardiography to define the anatomic and functional remodeling that results from MitraClip implantation. A total of sixty (60) patients undergoing MitraClip implantation will be enrolled across multiple sites. The severity of mitral regurgitation, cardiac morphology and function will be assessed in these patients by taking cardiac magnetic resonance imaging with an FDA approved contrast agent at BASELINE (within 30 days prior to MitraClip implantation), during the ACUTE REMODELING PHASE (pre-discharge following implantation), and during the CHRONIC REMODELING PHASE (6 months post-implantation).
Primary Outcome
Serial CMR scans obtained to document changes in the ventricular remodeling
Interventions
- DIAGNOSTIC_TEST Blood sample
- DIAGNOSTIC_TEST Cardiac MRI with or without contrast dye
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-01 |
| Est. Completion | 2021-12 |
What the finished NCT02924363 record still lists
NCT02924363 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Blood sample is the first listed.
NCT02924363 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02924363 about?
NCT02924363 is a clinical study titled "Effect of MitraClip on Acute and Chronic Reverse Cardiac Remodeling Assessed by CMR: The MITRA-REVERSE Study". The purpose of this study is to use cardiac magnetic resonance (CMR) and echocardiography to define the anatomic and functional remodeling that results from MitraClip implantation. A total of sixty (60) patients undergoing MitraClip implantation will be enrolled across multiple sites. The severity o...
What is the current status of trial NCT02924363?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2017-01. Estimated completion is 2021-12.
What interventions are being tested in trial NCT02924363?
The interventions under investigation include: Blood sample (DIAGNOSTIC_TEST), Cardiac MRI with or without contrast dye (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02924363?
This trial is sponsored by Dipan Shah, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia